Cognitive and Behavioral Therapy in School Refusal (RSA-Coll)

July 17, 2024 updated by: University Hospital, Montpellier

Anxious School Refusal in Adolescents: Efficiency of a Cognitive and Behavioral Therapy (CBT) Day Hospital Program

Anxious school refusal (ASR) is a common disorder which concerns more and more adolescents who are at worse completely absent from school. A specific ambulatory cognitive and behavioral therapy (CBT) program has been established to gradually reintegrate the child back into the school environment with a multidisciplinary team. Alongside school reintegration assessment, the child's overall ability to function and anxiety levels will be measured before and after the program with additional assessments made after a further 6 and 12 months have elapsed.

Study Overview

Detailed Description

ASR concerns children and adolescents who feel anxiety about going to school. Some are totally absent, some just have difficulty remaining in school for the entire day, or go to school following behavioral problems such as morning tantrums or psychosomatic complaints. Anxiety disorders are the main diagnostic underlying this behavioral problem, with one or many anxiety disorders associated (i.e. separation anxiety disorder, panic disorder, social anxiety disorder, generalized anxiety disorder or specific phobia). ASR causes much distress to the child, the parents, and the school personnel and interferes with social and educational development. Children with severe or chronic school refusal appear to have a long-term risk of adult mental health issues (e.g. anxiety, depression). Studies about ASR are few, and nonexistent in France. ASR occurs in approximately 1% of all school-aged children, and 5% of all clinic-referred children, is equally common in both boys and girls but more frequent in adolescents. Recommendations for anxiety disorder treatment in youth is psychotherapy. CBT, especially exposure-based, is the intervention that is supported by numerous, randomized, controlled trials in this area. But concerning ASR, there are few studies.

A specific ambulatory therapeutic CBT program for totally absent from school adolescents is established within the children and adolescent psychiatric unit in the University Hospital of Montpellier, France. The unit has implemented CBT techniques to gradually reintegrate the child back into the school environment. This program will be implemented in 3 other child and adolescent psychiatry centers (Marseille, Béziers and Nîmes).

The main objective of this study is to evaluate the efficiency of a CBT program on the return back to school.

Secondary objectives are:

  1. To evaluate the feasibility in implantation of this program
  2. To describe the characteristics of adolescents
  3. To assess the initial severity of mental disorders and the evolution of these disorders
  4. To describe the evolution of patient anxiety
  5. To describe the evolution of the overall functioning
  6. To evaluate the efficiency on the return back to school at 6 and 12 month after intervention.

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • Montpellier University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 12 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion criteria:

  • Adolescents between 10 and 16 years old registered in French college (6è to 3è),
  • Anxious school refusal based on Berg's criteria,
  • Completely dropped out from school (>5 consecutive days of school nonattendance, absenteeism < 12 months),
  • Anxiety disorder as a principal diagnosis (DSM 5)(MINI -S KID),
  • Adolescents want to return to school,
  • Signed consent by parents and adolescents

Exclusion criteria:

  • Intellectual disabilities
  • Autism spectrum disorder
  • Learning disabilities that causes emotional trouble and being the primary cause of teenagers dropping out of school.
  • Conduct disorder (DSM 5)
  • Ongoing psychotherapeutic care that the parents or the adolescent would not wish to suspend
  • Participation in other ongoing research
  • Pregnancy
  • Patient not benefiting from a social security scheme

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Anxious school refusal
Adolescents with anxious shool refusal will beneficiate of cognitive and behavioral therapy (CBT) in order to help them to return back to school

The CBT program is delivered by a multidisciplinary team with 4 half day hospitalization that includes individual, group CBT and education time (2 hours per day delivered by the teacher). Participants have homework to do in their own time at home.

CBT is a manualized program with anxiety psychoeducation, stress management, cognitive restructuration, problem solving techniques, progressive exposure, assertiveness exercises and self-esteem work.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
School continue reintegration
Time Frame: 46 months
The return back to school next year : school continue reintegration (number of hours the adolescent attended school > 80% of the number of hours expected for each patient
46 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Types of anxiety disorders according to the DSM 5
Time Frame: 46 months
The questionnaire Mini-International Neuropsychiatric Interview for Children and Adolescents (MINI-S KID) is completed with parents and the adolescent
46 months
Presence of comorbidities
Time Frame: 46 months
Presence of comorbidities is evaluated by the questionnaire Mini-International Neuropsychiatric Interview for Children and Adolescents (MINI-S KID) completed with parents and the adolescent
46 months
Initial severity of mental disorders and the evolution of these disorders
Time Frame: 46 months
Mesure thanks to the Clinical Global Impression (CGI) scale.
46 months
Anxiety assessment
Time Frame: 46 months
Mesure thanks to the Anxiety and Phobia Behavioural (ECAP) Scale
46 months
Anxiety assessment
Time Frame: 46 months
Mesure thanks to the scales Revisited Children's Manifest Anxiety scale (RCMAS)
46 months
Anxiety assessment
Time Frame: 46 months
Mesure thanks to the scales Multidimensional Anxiety Scale for Children (MASC)
46 months
Global functioning
Time Frame: 46 months
Mesure thanks to the scale Children's global Assessment (C GAS) Scale
46 months
School attendance time month by month
Time Frame: 46 months
46 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hélène DENIS, Montpellier University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 22, 2020

Primary Completion (Actual)

May 22, 2023

Study Completion (Actual)

July 8, 2024

Study Registration Dates

First Submitted

August 18, 2020

First Submitted That Met QC Criteria

September 16, 2020

First Posted (Actual)

September 23, 2020

Study Record Updates

Last Update Posted (Actual)

July 18, 2024

Last Update Submitted That Met QC Criteria

July 17, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RECHMPL20_0048

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adolescent

Clinical Trials on cognitive and behavioral therapy (CBT)

Subscribe